Results 101 to 110 of about 146,730 (293)
The problem of propranolol poisoning
Aims Propranolol is licensed in the UK and elsewhere to relieve symptoms of anxiety. In overdose, propranolol poisoning can be serious, difficult to treat and potentially fatal. This paper describes cases of intentional propranolol overdose reported to the UK National Poisons Information Service in order to raise awareness of the risk of harm following
Hayley Williams+8 more
wiley +1 more source
Relationship of Hypoxia to Arrhythmia and Cardiac Conduction Hemorrhage [PDF]
Richard E. Clark+5 more
openalex +1 more source
Cardiac Arrhythmias Associated with Succinylcholine in a Patient with Pheochromocytoma [PDF]
Theodore K. Stoner, KARL F. URBACH
openalex +1 more source
ABSTRACT The subfamily Gomphrenoideae is composed of about 480 accepted species, many of which have been historically used as medicinal plants, reason why they have been studied in terms of chemical profile, biological activity, and safety. This review consolidates the advances in research on this subfamily over the past 47 years, emphasizing its ...
Dayanna Isabel Araque Gelves+3 more
wiley +1 more source
Atrial fibrillation (AF) is a prevalent arrhythmia, while pulmonary vein isolation (PVI) has become a cornerstone in its treatment. The creation of durable lesions is crucial for successful and long-lasting PVI, as inconsistent lesions lead to ...
Ely Gracia+6 more
doaj +1 more source
Beta-adrenergic blockade and cardiac arrhythmias. [PDF]
Graeme Sloman, Mary Stannard
openalex +1 more source
ABSTRACT This study investigated the flavonoid compounds and their biological activities in methanol extracts obtained from root, stem, leaf, and flower parts of Amaranthus retroflexus L. Flavonoids in the extracts were characterized for the first time by liquid chromatography–highresolution mass spectrometry (LC–HRMS), and a total of eight flavonoid ...
Bedrettin Selvi+6 more
wiley +1 more source
Observations on the Mechanism of Succinyldicholine-Induced Cardiac Arrhythmias [PDF]
David A. Schoenstadt+1 more
openalex +1 more source
ABSTRACT Background The effects of phosphodiesterase 5 (PDE5) inhibitors on the incidence of long‐term outcomes in patients with cardiovascular disease are not well understood. Objective: We studied the association between PDE5 inhibitor therapy and the incidence of adverse cardiovascular major adverse cardiovascular events (MACE) in patients ...
Sumon Roy+5 more
wiley +1 more source